United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$77Mraised across 6 rounds since 2010, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Nov 2012
No investor was named in the report.
Reported by finance.yahoo.comSEC filing: $3.0M sold, first sale Nov 2012
No investor was named in the report.
Reported by sec.govSEC filing: $28M sold, first sale Jul 2010
Novartis Venture Fund
GBS Ventures
Venture InvestorsReported by masshightech.comSEC filing: $22M sold, first sale Jul 2010
Reported by euthymics.comSEC filing: $5.2M sold, first sale Jul 2010
From the SEC filings it signed: 3 on the team.
On the board, as filediBrigitte SmithCampbell MurrayDaniel OmsteadJeffrey BaileyPaul WeissTimothy Barberich
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
GBS VenturesNovartis Venture FundVenture InvestorsHambrecht & Quist Capital ManagementH&Q Venture CapitalMissing a round, or an investor who was in one? Tell us.
Euthymics Bioscience's investors include GBS Ventures, Novartis Venture Fund, Venture Investors, Hambrecht & Quist Capital Management and H&Q Venture Capital.
Euthymics Bioscience has raised $77M across 6 rounds since 2010.
Euthymics Bioscience's most recent round was a Series A of $11M in Apr 2014.
Euthymics Bioscience's largest round on record is $28M (Series A), in Jun 2012.
Euthymics Bioscience's first round on record, in Jul 2010, was backed by GBS Ventures and Hambrecht & Quist Capital Management.
Euthymics Bioscience's latest named round is a Series A, in Apr 2014.
Euthymics Bioscience is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
